Connect with us
The U.S. has reclassified cannabis from Schedule I to Schedule III, recognizing its medical use and easing research restrictions. The change reduces tax burdens for cannabis...
Cannabis stocks, including Tilray, plunged after a 2021 speculative peak, remaining in long-term decline. Momentum may shift as U.S. authorities consider reclassifying cannabis. Tilray shows technical...
Misiones’ government will dissolve its medicinal cannabis company, MisioPharma, to improve efficiency and cut costs. Governor Hugo Passalacqua cited a mature global market, economic crisis, and...
Snoop Dogg expands his cannabis brand in the US with Sensi Seeds, launching five carefully tested strains after a European debut. Focused on flavor, potency, and...
Two years after partial cannabis legalization in Germany, 413 cultivation clubs have been established nationwide. Lower Saxony leads in clubs per capita, while Bavaria has the...
Two years after Germany’s partial cannabis legalization, an evaluation finds no significant rise in consumption and some reduction in the black market. However, limited cultivation associations...
Lowryder is a groundbreaking cannabis strain that introduced autoflowering, allowing plants to flower automatically without light changes. Created by The Joint Doctor, it is compact, fast-growing,...
Poland’s Centre parliamentary group proposed a bill to decriminalize cannabis, allowing possession of up to 15 grams and one homegrown plant without penalties. Supporters argue current...
In March 2026, Aurora exited the recreational cannabis market to focus on higher-margin global medical cannabis. With 81% of revenue from medical sales, growth is driven...
Germany’s medical cannabis market is booming after 2024 legal reforms reclassified cannabis as a prescription drug, boosting access and imports from 72.85 to 201 tons. Telemedicine,...